What equity-related instruments are tied to CareCloud’s new financing?

As consideration for a securities account pledge, Executive Chairman Mahmud Haq will receive a five-year warrant exercisable for 4,300,000 common shares at $5.00 per share. CareCloud also established an at-the-market program allowing sales of up to $60 million of common stock through Citizens JMP Securities.

CareCloud (Nasdaq: CCLD) secures $50M facility and plans full preferred redemption

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

CareCloud, Inc. entered into a new Credit Agreement providing a $40 million term loan and a $10 million revolving credit facility maturing on the fourth anniversary of closing. The loans are secured by substantially all company and subsidiary assets and carry interest based on SOFR or an alternate base rate plus a margin.

As part of the collateral package, Executive Chairman Mahmud Haq will pledge certain securities accounts and receive a five-year warrant exercisable for 4,300,000 common shares at $5.00 per share. The company also put in place an at-the-market equity program to sell up to $60 million of common stock through Citizens JMP Securities.

CareCloud elected to redeem all 1,511,372 outstanding shares of its 8.75% Series B Preferred Stock on May 15, 2026 at $25.25 per share plus $2.27 of accrued dividends, for total cash of $27.52 per share. The redemption is expected to eliminate approximately $3.2 million in annual preferred dividends; management notes the company generates about $30 million in annualized adjusted EBITDA.

Positive

Elimination of expensive preferred dividends: Redeeming 1,511,372 Series B preferred shares at a total of $27.52 per share is expected to remove approximately $3.2 million in annual dividend obligations, meaningful relative to about $30 million in annualized adjusted EBITDA.
Secured institutional credit facility: A new $40 million term loan plus $10 million revolving credit facility from Citizens Bank and Provident Bank provides committed, institutional-grade financing and supports a shift from higher-cost preferred equity to lower-cost debt.

Negative

Potential equity dilution from warrant and ATM: Consideration for the collateral pledge includes a warrant for 4,300,000 common shares at $5.00 per share, and a new at-the-market program authorizes up to $60 million of common stock sales, creating potential future dilution.

Insights

New debt replaces costly preferred equity, cutting annual cash outflows.

CareCloud has arranged a $40 million term loan and a $10 million revolver secured by substantially all assets. Management states the facilities help fund the full redemption of its 8.75% Series B Preferred Stock, which carried a high dividend rate.

Redeeming 1,511,372 preferred shares at a total price of $27.52 per share removes about $3.2 million in annual preferred dividends. With annualized adjusted EBITDA around $30 million, that reduction is sizable and should improve fixed-charge coverage, though it increases secured leverage and adds covenant constraints.

The financing package also includes a warrant for 4,300,000 common shares at $5.00 and an at-the-market program authorizing up to $60 million of common stock sales. These tools provide liquidity and flexibility but introduce potential future equity dilution depending on share issuance levels under the ATM and warrant exercise.

8-K Event Classification

5 items: 1.01, 2.03, 3.02, 8.01, 9.01

5 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial

The company incurred a new significant debt or off-balance-sheet obligation.

Item 3.02 Unregistered Sales of Equity Securities Securities

The company sold equity securities in a private placement or other unregistered transaction.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

Credit facility size: $40.0 million term loan + $10.0 million revolver ATM program capacity: $60 million common stock Preferred shares redeemed: 1,511,372 shares +4 more

7 metrics

Credit facility size $40.0 million term loan + $10.0 million revolver Credit Agreement dated April 13, 2026

ATM program capacity $60 million common stock At The Market Offering Agreement

Preferred shares redeemed 1,511,372 shares Series B Preferred Stock redemption on May 15, 2026

Total redemption price per share $27.52 per share $25.25 redemption price + $2.27 accrued dividends

Annual dividend savings $3.2 million per year Elimination of Series B preferred dividends

Annualized adjusted EBITDA $30 million Company statement on operating performance

Warrant size and strike 4,300,000 shares at $5.00 per share Warrant issued to Executive Chairman as pledge consideration

Key Terms

Credit Agreement, at the market offering, Series B Cumulative Redeemable Perpetual Preferred Stock, warrant, +2 more

6 terms

Credit Agreement financial

"CareCloud, Inc. entered into a Credit Agreement with Citizens Bank, N.A."

A credit agreement is a written loan contract between a borrower and a bank or other lender that lays out how much money can be borrowed, the interest rate, repayment schedule, fees, and the rules the borrower must follow. For investors, it matters because those terms affect a company’s cash costs, borrowing flexibility and risk of default — similar to how a mortgage’s rules determine a homeowner’s monthly budget and freedom to make changes.

at the market offering financial

"entered into an At The Market Offering Agreement under which it may sell shares"

An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.

Series B Cumulative Redeemable Perpetual Preferred Stock financial

"elected to redeem all of the issued and outstanding shares of its Series B Cumulative Redeemable Perpetual Preferred Stock"

warrant financial

"will receive a warrant exercisable for 4,300,000 shares of common stock at a strike price of $5.00 per share"

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

Term SOFR financial

"Borrowings under the Credit Facility bear interest at rates based on Term SOFR, Daily Simple SOFR or the alternate base rate"

Term SOFR is a benchmark interest rate that reflects the cost of borrowing money over a specific period, based on actual transactions in the financial markets. It is used by lenders and borrowers to set the interest rates on loans and financial contracts, helping to ensure rates are fair and transparent. For investors, understanding term SOFR helps gauge borrowing costs and the overall direction of interest rates in the economy.

adjusted EBITDA financial

"CareCloud currently generates approximately $30 million in annualized adjusted EBITDA"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

Understanding 8-K Material Events →

04/14/2026 - 07:05 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 13, 2026

CareCloud, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-36529

22-3832302

(State or other jurisdiction of

incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

7 Clyde Road, Somerset, New Jersey 08873
(Address of principal executive offices, zip code)

(732) 873-5133

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	CCLD	Nasdaq Global Market
8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share	CCLDO	Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

Credit Agreement

On April 13, 2026, CareCloud, Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with Citizens Bank, N.A., as administrative agent, issuing bank and a lender (“Citizens”), Provident Bank, as a lender (“Provident”), and the other parties thereto, which provides for a $40.0 million term loan facility and a $10.0 million revolving credit facility (collectively, the “Credit Facility”).

The term loan facility and the revolving credit facility each mature on the fourth anniversary of the closing date. The term loan amortizes in equal monthly principal installments beginning June 1, 2026. Borrowings under the Credit Facility bear interest at rates based on Term SOFR, Daily Simple SOFR or the alternate base rate, in each case plus the applicable margin. The Credit Facility contains customary affirmative and negative covenants, including financial covenants, and customary events of default. The obligations under the Credit Facility are guaranteed by certain of the Company’s subsidiaries and are secured by substantially all of the Company’s and such guarantors’ assets.

As a post-closing condition, within 45 days from the closing date, Mahmud Haq, the Company’s Executive Chairman, will enter into a Securities Account Pledge Agreement in favor of Citizens, as administrative agent, pursuant to which he will pledge certain securities accounts as additional collateral support for the Credit Facility. In consideration for this pledge, Mr. Haq will receive a warrant exercisable for 4,300,000 shares of common stock of the Company at a strike price of $5.00 per share (the “Warrant”). This Warrant will have a term of five years and will have customary anti dilution provisions and a net share settlement feature. Upon execution and delivery of the Securities Account Pledge Agreement and the Warrant, the Company will file an amendment to this Current Report on Form 8-K to include the executed Securities Account Pledge Agreement and Warrant as exhibits hereto.

The proceeds of the Credit Facility will be used for general corporate purposes, including the redemption of the Company’s outstanding 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”). Such redemption is described further in Item 8.01 below.

The foregoing descriptions of the Credit Facility, the Securities Account Pledge Agreement and Warrant do not purport to be complete and are qualified in their entirety by reference to the definitive agreements, copies of which are attached hereto, or upon execution, will be attached to an amendment thereto, as exhibits and are incorporated herein by reference.

ATM Agreement

Also, on April 13, 2026, the Company entered into an At The Market Offering Agreement (the “ATM Agreement”) with Citizens JMP Securities, LLC (“Citizens”), pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $60 million (the “Shares”) from time to time through or to Citizens, acting as sales agent or principal.

The Shares will be offered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-286431) and a prospectus supplement filed on April 14, 2026.

Upon the entry into a separate Terms Agreement (as defined in the ATM Agreement) and subject to the terms and conditions of the ATM Agreement, Citizens may sell the Shares by any method permitted by law deemed to be an “at the market” offering as defined in Rule 415 of the Securities Act of 1933, as amended, including, without limitation, sales made through The Nasdaq Global Market or on any other existing trading market for the Company’s common stock. Citizens will use commercially reasonable efforts to sell the Shares from time to time, based upon instructions from the Company. Under the terms of the ATM Agreement, Citizens will be entitled to a commission of 3.0% of the gross proceeds from any Shares sold under the ATM Agreement. The Company has also provided Citizens with customary indemnification and contribution rights.

The Company is not obligated to sell any Shares under the ATM Agreement and intends to use any proceeds from sales made under the ATM Agreement for general corporate purposes, which may include funding potential acquisitions, loan repayments, organic growth initiatives, capital expenditures, investments and general working capital, as well as redemption of our preferred stock.

Song P.C., counsel to the Company, has issued a legal opinion relating to the Shares. A copy of such legal opinion, including the consent included therein, is attached as Exhibit 5.1 hereto.

The foregoing description of the ATM Agreement is qualified in its entirety by reference to the full text of the agreement, a copy of which is attached hereto as Exhibit 10.13 and is incorporated herein by reference.

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 2.03.

Item 3.02. Unregistered Sales of Equity Securities.

To the extent required by Item 3.02 of Form 8-K, the information set forth under Item 1.01 of this Current Report on Form 8-K regarding the future issuance of the Warrant is incorporated herein by reference into this Item 3.02. The Warrant and the shares issuable upon exercise thereof will be issued in reliance on the applicable exemption from registration under the Securities Act of 1933, as amended.

Item 8.01 Other Events.

On April 14, 2026, the Company announced that it has elected to redeem 1,511,372 shares (the “Redeemed Shares”) of its Series B Preferred Stock, consisting of all of the issued and outstanding shares of its Series B Preferred Stock, pursuant to the Certificate of Designation governing the Series B Preferred Stock.

The Company has set a redemption date of May 15, 2026 (the “Redemption Date”), following the required 30-day notice period. The redemption is being made pursuant to the Company’s optional redemption right set forth in Section 6(b) of the Certificate of Designations.

The Redeemed Shares will be redeemed at a cash redemption price of $25.25 per share, plus all accrued and unpaid dividends (whether or not declared) up to, but not including, the Redemption Date in an amount equal to $2.27 per share, for a total payment of $27.52 per share. From and after the Redemption Date, dividends on the Redeemed Shares will cease to accumulate, the Redeemed Shares will no longer be outstanding, and all rights of the holders of such shares will terminate, except the right of the holders to receive the cash payable upon such redemption, without interest.

This Current Report on Form 8-K is intended, in part, to provide public notice of the Company’s election to redeem the Series B Preferred Stock. Notice has been given to Nasdaq and DTCC regarding the redemption.

On April 14, 2026, the Company issued a press release and a notice of redemption announcing the redemption of the Series B Preferred Stock. A copy of the press release and notice of redemption are attached as Exhibit 99.1 and Exhibit 10.14 and are incorporated herein by reference.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s redemption of preferred securities, financing arrangements, and future financial performance. Actual results may differ materially due to various risks and uncertainties.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

5.1	Opinion of Song P.C.
10.1	Credit Agreement dated April 13, 2026 by and among CareCloud, Inc. and Citizens Bank, N.A. as administrative agent.
10.2	Pledge and Security Agreement
10.3	Pledge Agreement
10.4	Citizen Term Loan Note
10.5	Provident Term Loan Note
10.6	Citizens Revolving Loan Note
10.7	Provident Revolving Loan Note
10.8	Swingline Loan Note
10.9	Trademark Security Agreement
10.10	Guarantee Agreement
10.11	Copyright Security Agreement
10.12	Patent Security Agreement
10.13	At The Market Offering Agreement, dated April 13, 2026, by and between CareCloud, Inc. and Citizens JMP Securities, LLC
10.14	Notice of Redemption
23.1	Consent of Song P.C. (included in exhibit 5.1 above)
99.1	Press Release dated April 14, 2026.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE(S)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CareCloud, Inc.

Date: April 14, 2026	By:	/s/ Norman Roth
		Norman Roth
		Interim Chief Financial Officer and Corporate Controller

Exhibit 99.1

CareCloud Secures $50 Million Credit Facility and Full Redemption of Series B Preferred Stock

Facility with Citizens Bank and Provident Bank underscores strong access to institutional capital

SOMERSET, NJ – April 14, 2026 – CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of AI-driven healthcare technology and revenue cycle management solutions, today announced the closing of a $50 million credit facility on April 13, 2026, with Citizens Bank, N.A. (“Citizens”) and Provident Bank, a subsidiary of Provident Financial Services, Inc (“Provident Bank”). Citizens acted as lead arranger and administrative agent on the $50 million credit facility. Provident Bank participated in the financing.

The Company also announced that, on May 15, 2026, it will redeem 100% of its outstanding 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) (the “Series B Preferred Stock”) , following the requisite 30-day notice period. This milestone simplifies in the Company’s capital structure, eliminates preferred equity overhang, and enhances long-term shareholder value. The redemption is expected to eliminate approximately $3.2 million in annual preferred dividend obligations and replace higher-cost preferred equity with lower-cost institutional debt, improving the Company’s capital structure and enhancing long-term financial flexibility.

CareCloud currently generates approximately $30 million in annualized adjusted EBITDA, which underscores the strength of its operating model and has enabled its transition to lower-cost, institutional-grade financing. The facility reflects continued execution of the Company’s transformation strategy. It provides non-dilutive capital, enhances liquidity and financial flexibility, lowers the cost of capital, and reinforces operational resilience. CareCloud also continues to expand its AI-driven platform, applying automation across healthcare operations to improve efficiency, scalability, and resilience.

“This transaction represents a transformative step for CareCloud,” said Stephen Snyder, Chief Executive Officer of CareCloud. “With the full redemption of the Series B Preferred Stock, we are simplifying our capital structure and positioning the Company for its next phase of growth. We believe this strengthens our financial profile and enhances our ability to attract a broader base of institutional investors.”

In connection with the transaction, Matthew Rickert, Market Executive, and Alan Tekerlek, Managing Director, of Citizens stated, “We are pleased to have partnered closely with the Company to optimize its capital structure and strategically position CareCloud for sustained growth and enhanced profitability.”

With its capital structure simplified, the Company is entering the next phase of its strategic evolution focused on accelerating growth and enhancing long-term shareholder value. The Company intends to leverage its strengthened balance sheet and improved financial flexibility to further expand its AI-enabled product offerings, drive organic growth across its core revenue cycle management platform, and pursue strategic initiatives to increase scale and operating leverage.

Redemption Details

All 1,511,372 outstanding shares of the Series B Preferred Stock (CUSIP No. 14167R308) will be redeemed on May 15, 2026 (the “Redemption Date”). Each share will be redeemed at a price equal to $25.25 per share (the “Redemption Price”), plus an amount equal to any accumulated and unpaid dividends on such shares up to, but not including, the Redemption Date, totaling $2.27 for a total of $27.52 per share (the “Total Redemption Price”). On and after the Redemption Date, dividends will cease to accrue on the Series B Preferred Stock, and all rights of holders will terminate except for the right to receive the Total Redemption Price. In connection with this process, the Company will delist the Series B Preferred Stock from the Nasdaq Global Stock Market.

The Series B Preferred Stock is held in book-entry form through the Depository Trust Company (“DTC”), and the shares will be redeemed in accordance with the applicable procedures of the DTC and the Certificate of Designations, Preferences and Rights of the Series B Preferred Stock (the “Certificate of Designations”). Payment to DTC for the Series B Preferred Stock will be made by VStock Transfer, LLC, as redemption agent, who has received the full amount of the funds to effect the transaction.

This press release does not constitute a notice of redemption under the Certificate of Designations governing the Series B Preferred Stock and is qualified in its entirety by reference to the notice of redemption issued by the Company, which will be delivered to the DTC in accordance with the terms of the Certificate of Designations.

About CareCloud

CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 45,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.

Follow CareCloud on LinkedIn, X and Facebook.

For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases, and view the latest investor presentation, please visit ir.carecloud.com.

About Citizens Financial Group, Inc.

Citizens Financial Group, Inc. is one of the nation’s oldest and largest financial institutions, with $226.4 billion in assets as of December 31, 2025. Headquartered in Providence, Rhode Island, Citizens offers a broad range of retail, private banking, wealth management and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations and institutions. Citizens helps its customers reach their potential by listening to them and by understanding their needs in order to offer tailored advice, ideas and solutions. In Consumer Banking, Citizens provides an integrated experience that includes mobile and online banking, a full-service customer contact center and the convenience of approximately 3,100 ATMs and approximately 1,000 branches in 14 states and the District of Columbia. Consumer Banking products and services include a full range of banking, lending, savings, wealth management and small business offerings. Consumer Banking includes Citizens Private Bank and Private Wealth, which integrate banking services and wealth management solutions to serve high- and ultra-high-net-worth individuals and families, as well as investors, entrepreneurs and businesses. In Commercial Banking, Citizens offers a broad complement of financial products and solutions, including lending and leasing, deposit and treasury management services, foreign exchange, interest rate and commodity risk management solutions, as well as loan syndication, corporate finance, merger and acquisition, and debt and equity capital markets capabilities. More information is available at www.citizensbank.com or visit us on X, LinkedIn or Facebook.

Forward-Looking Statements

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE: CareCloud

Company Contact:

Norman Roth

Interim Chief Financial Officer and Corporate Controller

CareCloud, Inc.

nroth@carecloud.com

Investor Contact:

Stephen Snyder

Chief Executive Officer

CareCloud, Inc.

ir@carecloud.com

Source: View Original Filing on SEC EDGAR

FAQ

What new financing did CareCloud (CCLD) secure in this 8-K?

CareCloud entered a Credit Agreement providing a $40 million term loan and a $10 million revolving credit facility. The loans are secured by substantially all company and guarantor assets and bear interest based on SOFR or an alternate base rate plus an applicable margin.

How is CareCloud using the new credit facility and ATM program?

CareCloud plans to use the $50 million credit facility and any proceeds from its $60 million at-the-market equity program for general corporate purposes. These include redeeming its Series B preferred stock, funding potential acquisitions, repaying loans, supporting growth initiatives and working capital.

What are the terms of CareCloud’s Series B preferred stock redemption?

CareCloud elected to redeem all 1,511,372 outstanding Series B Preferred shares on May 15, 2026. Each share will be redeemed at $25.25 plus $2.27 in accrued and unpaid dividends, for total cash consideration of $27.52 per share, after which dividends cease and related holder rights terminate.

How much will CareCloud save by redeeming its Series B preferred stock?

The company expects the full redemption of its 8.75% Series B Preferred Stock to eliminate approximately $3.2 million in annual dividend obligations. Management highlights this reduction alongside about $30 million in annualized adjusted EBITDA, indicating a material improvement in recurring cash outflows.

Will CareCloud’s preferred stock remain listed after the redemption?

All 1,511,372 Series B Preferred shares will be redeemed on May 15, 2026, at $27.52 per share including accrued dividends. In connection with this process, the company plans to delist the Series B Preferred Stock from the Nasdaq Global Stock Market following completion of the redemption procedures.

Filing Exhibits & Attachments

23 documents

CareCloud (Nasdaq: CCLD) secures $50M facility and plans full preferred redemption